TIAA-CREF INDIVIDUAL & INSTITUTIONAL SERVICES, LLC
Position in NVS — Novartis AG
CIK 882928
CHARLOTTE, NC
Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,383,837
+$66,674 QoQ
Shares Held
8,830
+2.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#528
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TIAA-CREF INDIVIDUAL & INSTITUTIONAL SERVICES, LLC holds $175,721,943 across 13 Drug Manufacturers - General names. NVS ranks #9 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
213,596 | $54,246,976 | |
| 2 | LLY |
ELI LILLY & Co
|
39,604 | $47,502,229 | |
| 3 | ABBV |
AbbVie Inc.
|
109,397 | $27,528,661 | |
| 4 | MRK |
Merck & Co., Inc.
|
116,389 | $14,955,986 | |
| 5 | AMGN |
Amgen Inc
|
33,159 | $12,007,537 | |
| 6 | PFE |
Pfizer Inc
|
248,937 | $5,994,402 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
83,879 | $4,833,107 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
38,084 | $4,811,532 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,383,837 | 8,830 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $1,317,163 | 8,623 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||